BGF European Value X2 |
Performance History | 30/09/2024 |
Growth of 1,000 (EUR) |
Fund | 5.1 | 23.7 | -3.0 | 16.0 | 16.2 | |
+/-Cat | 12.9 | 0.9 | 4.9 | 0.9 | 5.8 | |
+/-Idx | - | - | - | 0.1 | 4.7 | |
Category: Europe Large-Cap Value Equity | ||||||
Benchmarks: Morningstar DM Europe Val T... |
Key Stats | ||
NAV 25/10/2024 | EUR 17.59 | |
Day Change | -0.62% | |
Morningstar Category™ | Europe Large-Cap Value Equity | |
ISIN | LU1333799911 | |
Fund Size (Mil) 30/09/2024 | EUR 825.58 | |
Share Class Size (Mil) 25/10/2024 | EUR 51.97 | |
Max Initial Charge | - | |
Ongoing Charge 16/04/2024 | 0.06% |
Investment Objective: BGF European Value X2 |
The Fund seeks to maximise total return. The Fund invests at least 70% of its total assets in the equity securities of companies domiciled in, or exercising the predominant part of their economic activity in, Europe. The Fund places particular emphasis on companies that are, in the opinion of the Investment Adviser, undervalued and therefore represent intrinsic investment value. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Brian Hall 30/11/2010 | ||
Peter Hopkins 01/03/2021 | ||
Inception Date 16/12/2015 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe Value NR EUR | Morningstar DM Europe Val TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BGF European Value X2 | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Sanofi SA | Healthcare | 3.96 |
Compagnie de Saint-Gobain SA | Industrials | 3.54 |
UniCredit SpA | Financial Services | 3.46 |
Unilever PLC | Consumer Defensive | 3.31 |
Siemens AG | Industrials | 2.98 |
Increase Decrease New since last portfolio | ||
BGF European Value X2 |